BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28557595)

  • 21. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
    Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
    Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.
    Saba KH; Cornmark L; Rissler M; Fioretos T; Åström K; Haglund F; Rosenberg AE; Brosjö O; Nord KH
    Genes Chromosomes Cancer; 2019 Oct; 58(10):731-736. PubMed ID: 31066955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cartilage-forming tumors.
    Qasem SA; DeYoung BR
    Semin Diagn Pathol; 2014 Jan; 31(1):10-20. PubMed ID: 24680178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chondroblastoma-like chondroma of soft tissue: report of the first case in the base of skull.
    Raparia K; Lin JW; Donovan D; Vrabec JT; Zhai QJ; Ayala AA; Ro JY
    Ann Diagn Pathol; 2013 Jun; 17(3):298-301. PubMed ID: 22743240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alterations of MDM2 and p53 genes in bone tumors].
    Zhou X; Gao L; Zhe X
    Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):270-2. PubMed ID: 10374333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distal Femoral Non-Epiphyseal Cortical Chondroblastoma Confirmed with
    Gu H; Sun L; Cui J; Yu L; Wang J
    Fetal Pediatr Pathol; 2023 Apr; 42(2):320-326. PubMed ID: 36048092
    [No Abstract]   [Full Text] [Related]  

  • 27. Chondroblastoma-like osteosarcoma.
    Martin KL; Firestone DE; McGarry SV; Dorfman HD; Kazmi SA
    Pathol Int; 2014 Aug; 64(8):409-11. PubMed ID: 25143130
    [No Abstract]   [Full Text] [Related]  

  • 28. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
    Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
    Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clear cell chondrosarcoma: report of a case].
    Shi HQ; Liu QW; Lou SX
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):498-9. PubMed ID: 17845769
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bone tumours: diagnostical problems--methodical possibilities (report) (author's transl)].
    Remagen W
    Verh Dtsch Ges Pathol; 1974; 58():219-35. PubMed ID: 4533374
    [No Abstract]   [Full Text] [Related]  

  • 31. Clear-cell chondrosarcomas: Fine-needle aspiration cytology, radiological findings, and patient demographics of a rare entity.
    Zhang Y; Alagic Z; Tani E; Skorpil M; Tsagkozis P; Haglund F
    Diagn Cytopathol; 2021 Jan; 49(1):46-53. PubMed ID: 32786062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
    Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
    Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chondroblastoma arising from a nonepiphyseal site.
    Brien EW; Mirra JM; Ippolito V
    Skeletal Radiol; 1995 Apr; 24(3):220-2. PubMed ID: 7610417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
    Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
    Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clear cell chondrosarcoma: a pathological and immunohistochemical study.
    Masui F; Ushigome S; Fujii K
    Histopathology; 1999 May; 34(5):447-52. PubMed ID: 10231420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone.
    Konishi E; Nakashima Y; Iwasa Y; Nakao R; Yanagisawa A
    Hum Pathol; 2010 Feb; 41(2):208-13. PubMed ID: 19801163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differential diagnosis of giant cell tumors].
    Protsenko VV
    Lik Sprava; 2003 Dec; (8):55-9. PubMed ID: 14965008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chondroblastoma: clinicopathological analyses of 307 cases from a single institution in China and the diagnostic value of the H3F3 K36M mutant antibody.
    Zhao Q; Tang J; Luo Y; Huang J; Hu D; Zhu J; Jiang T; Zhang H; Liu Z
    J Clin Pathol; 2023 Jun; 76(6):367-373. PubMed ID: 36604179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
    Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
    Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.